FSD Stock Recent News

First Trust High Inc Long/Short Fund has a higher yield than most other closed-end funds investing in high-yield bonds. The FSD closed-end fund has outperformed the Bloomberg U.S. Aggregate Bond Index and the Bloomberg High Yield Very Liquid Index over the past several months. The fund's leverage is slightly higher than its peers, but it is not a cause for concern.

TORONTO, ON / ACCESSWIRE / June 4, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today confirms that it has received institutional review board (IRB) approval for its METAL-2 trial in the USA. This IRB approval allows our team to begin recruiting clinical trial participants and to plan the execution of the clinical study.

PHILADELPHIA, PA / ACCESSWIRE / May 31, 2024 / The Board of Trustees of abrdn Income Credit Strategies Fund (NYSE:ACP), announces today that shareholders of First Trust High Income Long/Short Fund (NYSE:FSD) ("FSD" or the "Acquired Fund") advised by First Trust Advisors L.P. have approved the proposed reorganization into ACP ("Reorganization") which is targeted to be completed before the end of July or as soon as practicable thereafter, subject to the satisfaction of customary closing conditions.

WHEATON, Ill.--(BUSINESS WIRE)--First Trust Advisors L.P. (“FTA”) announced today the results of the joint special meeting of shareholders of each of First Trust High Income Long/Short Fund (NYSE: FSD) (“FSD”) and First Trust/abrdn Global Opportunity Income Fund (NYSE: FAM) (“FAM” and collectively with FSD, the “Funds”) held on May 30, 2024. Shareholders of FSD, a diversified, closed-end management investment company organized as a Massachusetts business trust, have approved the reorganization.

TORONTO, ON / ACCESSWIRE / May 31, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces that on May 29, 2024, the United States District Court for the Eastern District of Pennsylvania confirmed FSD Pharma, Inc.'s Petition to Confirm Arbitration Awards entered against Dr. Raza Bokhari by a Canadian arbitrator in 2022. Pursuant to the Federal Rules of Civil Procedure, FSD will now move for entry of final judgment against Bokhari, as follows: USD $147,301.04, plus interest at a rate of 4% per annum from November 9, 2022 until the date the Judgment is satisfied.

Craig Doty II, from Ohio, claimed his vehicle was in Full Self-Driving (FSD) mode at the time and didn't slow down despite the train crossing the road...

WHEATON, Ill.--(BUSINESS WIRE)--First Trust High Income Long/Short Fund (the "Fund") (NYSE: FSD) has declared the Fund's regularly scheduled monthly common share distribution in the amount of $0.105 per share payable on June 17, 2024, to shareholders of record as of June 3, 2024. The ex-dividend date is expected to be June 3, 2024. The monthly distribution information for the Fund appears below. First Trust High Income Long/Short Fund (FSD):               Distribution per share:               $.

TORONTO, ON / ACCESSWIRE / May 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu"), its new packaging and logo of unbuzzd™ expected to launch this summer, an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body's natural processes for metabolizing alcohol and promoting alertness. On May 16, 2024, Celly Nu and SIX+ONE unveil new packaging and logo for unbuzzd™ expected to launch this summer: Toronto, Ontario, May 16, 2024 - Celly Nutrition Corp, makers of unbuzzd™, a pioneering beverage company for innovative, cutting-edge alcohol metabolizing technology for recreational use products, is thrilled to announce the launch of its newly designed packaging and logo, meticulously crafted in collaboration with the renowned branding agency, Six+One.

First Trust High Income Long/Short Fund is a closed-end fund that focuses on high-yield bonds with a long/short strategy. FSD is a high fee product and has failed to deliver superior risk adjusted performance vs. passive high yield index ETFs. The fund's current discount to NAV is in line with historical average while most other CEFs are trading at historically wide discounts to NAV.

First Trust High Inc Long/Short Fund offers a 12.05% current yield and employs short sales as part of its investment strategy. The FSD ETF's performance has been disappointing, underperforming its benchmark and other bond index funds. The fund primarily invests in high-yield bonds, with a majority of its assets in BB or B-rated securities, indicating relatively low default risk.